- Research works
- 32 ▲ 277% vs 2013–17
- Citations
- 599 18.9 per fractional work
- Top-10% rate
- 23.8% record average 16.5%
- Open access
- 40% world 28%
Not ranked overall: CSL (Germany) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at CSL (Germany)?
By fractional works in all years, weighted toward what it does more of than the world: Hemostasis, Thrombosis, Prophylaxis, Recombinant Factor VIIa, Gene Therapy, Genetic Mutations, Factor VIII and Hemophilia.
- Immunosuppressive Therapy
- Protease-Activated Receptors
- Intravenous Immunoglobulin
- Risk Factors
- Chronic Hepatitis B
- Primary Immunodeficiency
- Immune Dysregulation
- Autoantibodies
- Antithrombotic Therapy
- Global Burden
- Immune Thrombocytopenic Purpura
- Molecular Basis
- Neurodegenerative Diseases
- Protein Aggregation
- Hemophilia
- Genetic Mutations
- Gene Therapy
- Epidemiology
- Inflammation
- Hemostasis
- Thrombosis
- Prophylaxis
- Recombinant Factor VIIa
- Factor VIII
- Diagnosis
- Immune Response
- Treatment
- Prion Diseases
- Platelets
- Pathogenesis
- Antiviral Therapy
- Hepatocellular Carcinoma
- Liver Disease
- Prognosis
- Hepatitis B Virus
- Angiogenesis
- Pregnancy
- Thrombin
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 38 words, with their numbers
- Hemostasis3▲ 69×3 topics
- Inflammation3▲ 4.2×5 topics
- Thrombosis3▲ 40×3 topics
- Epidemiology3▲ 2.1×14 topics
- Prophylaxis3▲ 60×2 topics
- Gene Therapy3▲ 30×2 topics
- Recombinant Factor VIIa3▲ 195×2 topics
- Genetic Mutations2▲ 15×5 topics
- Factor VIII2▲ 437×1 topic
- Hemophilia2▲ 437×1 topic
- Diagnosis2▲ 7.1×7 topics
- Protein Aggregation2▲ 86×2 topics
- Immune Response2▲ 11×4 topics
- Neurodegenerative Diseases2▲ 27×2 topics
- Treatment2▲ 4.7×5 topics
- Molecular Basis2▲ 371×1 topic
- Prion Diseases2▲ 371×1 topic
- Immune Thrombocytopenic Purpura2▲ 139×1 topic
- Platelets2▲ 86×1 topic
- Global Burden2▲ 8.8×3 topics
- Pathogenesis2▲ 8.5×5 topics
- Antithrombotic Therapy1▲ 41×2 topics
- Antiviral Therapy1▲ 29×3 topics
- Autoantibodies1▲ 19×3 topics
- Hepatocellular Carcinoma1▲ 20×2 topics
- Immune Dysregulation1▲ 50×1 topic
- Liver Disease1▲ 30×2 topics
- Primary Immunodeficiency1▲ 100×1 topic
- Prognosis1▲ 13×3 topics
- Chronic Hepatitis B1▲ 75×1 topic
- Hepatitis B Virus1▲ 75×1 topic
- Risk Factors1▲ 3.7×5 topics
- Angiogenesis1▲ 8.1×4 topics
- Intravenous Immunoglobulin1▲ 56×2 topics
- Pregnancy1▲ 16×2 topics
- Protease-Activated Receptors1▲ 94×1 topic
- Thrombin1▲ 94×1 topic
- Immunosuppressive Therapy1▲ 17×4 topics
Which research topics does CSL (Germany) publish most on?
By volume in 2022–2025: Hemophilia Treatment and Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Immunodeficiency and Autoimmune Disorders and Chronic Myeloid Leukemia Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemophilia Treatment and Research Hematology 1 works
- 2 Myeloproliferative Neoplasms: Diagnosis and Treatment Genetics 0 works
- 3 Immunodeficiency and Autoimmune Disorders Immunology 0 works
- 4 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 5 Virus-based gene therapy research Genetics 0 works
- 6 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 0 works
- 7 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works
- 8 Protein purification and stability Molecular Biology 0 works
- 9 Cardiovascular Function and Risk Factors Cardiology and Cardiovascular Medicine 0 works
- 10 Cardiac Fibrosis and Remodeling Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has CSL (Germany)'s research output changed?
Output in 2018–2022 was 277% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Hattersheim
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.